Public Health Weekly Report 2021; 14(23): 1648-1653
Published online June 3, 2021
© The Korea Disease Control and Prevention Agency
Hwang Joo-Yeon, Park So Yeon, Oh Kyungwon
Division of Rare Disease Management, Bureau of Chronic Disease Prevention and Control, KDCA
In Korea, according to the Rare Disease Act of 2016, a rare disease is defined as a condition that affects fewer than 20,000 persons. Patients with a rare disease receive a misdiagnosis more than once due to low prevalence and low awareness. Patients and their families endure an unpredictable journey, also referred to as a year-long diagnostic odyssey. These rare medical conditions cause excessive medical costs and long-term social burdens.
The purpose of this report was to summarize the findings from a rare disease genetic testing diagnostic program. Using genetic diagnosis workflow, this study achieved a diagnostic rate of 39.7% in 2020 and established the need for sustainable development. Also, this study anticipates that medically actionable genetic findings may increase the diagnostic yield in undiagnosed or misdiagnosed patients.
Key words Rare disease, Ultra rare disease, Gene, Genetic diagnosis
Public Health Weekly Report 2021; 14(23): 1648-1653
Published online June 3, 2021
Copyright © The Korea Disease Control and Prevention Agency.
Hwang Joo-Yeon, Park So Yeon, Oh Kyungwon
Division of Rare Disease Management, Bureau of Chronic Disease Prevention and Control, KDCA
In Korea, according to the Rare Disease Act of 2016, a rare disease is defined as a condition that affects fewer than 20,000 persons. Patients with a rare disease receive a misdiagnosis more than once due to low prevalence and low awareness. Patients and their families endure an unpredictable journey, also referred to as a year-long diagnostic odyssey. These rare medical conditions cause excessive medical costs and long-term social burdens.
The purpose of this report was to summarize the findings from a rare disease genetic testing diagnostic program. Using genetic diagnosis workflow, this study achieved a diagnostic rate of 39.7% in 2020 and established the need for sustainable development. Also, this study anticipates that medically actionable genetic findings may increase the diagnostic yield in undiagnosed or misdiagnosed patients.
Keywords: Rare disease, Ultra rare disease, Gene, Genetic diagnosis
Ye Eun Lee, Jee Young Kim, Jun Kil Choi, Young Bae Kim, Chong Kun Cheon
Public Health Weekly Report 2025; 18(37): 1393-1409 https://doi.org/10.56786/PHWR.2025.18.37.2Jiyoung Jang, Jun-kil Choi, Jee-Young Kim, Chong Hee Choi
Public Health Weekly Report 2025; 18(6): 305-319 https://doi.org/10.56786/PHWR.2025.18.6.3Hye-Won Jang, Jiwon M. Lee
Public Health Weekly Report 2024; 17(3): 90-103 https://doi.org/10.56786/PHWR.2024.17.3.2